| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
|---|---|
| Anti-ENA | Anti-Extractable Nuclear Antigens |
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| CREG | Cross REactive Group (of HLA Antigens) |
| ANA | acetylneuraminic acid; American Narcolepsy Association; American Neurological Association; American ... |
| public sector | The area of a nation's economy that is tax-supported and under government control. (12 Dec 1998) |
|---|---|
| public utility commissions | State agencies that regulate investor-owned utilities operating in the state. (05 Dec 1998) |
| public utility district | (PUD) A publicly owned energy producer or distributor. PUDs operate as special government districts under the authority of elected commissions. They are not regulated by public utility commissions. (05 Dec 1998) |
| public utility regulatory policies act | (PURPA) A federal law requiring a utility to buy the power produced by a qualifying facility at a price equal to that which the utility would otherwise pay if it were to build its own power plant or buy power from another source. (05 Dec 1998) |
| hospitals, public | Hospitals controlled by various types of government, i.e., city, county, district, state or federal. (12 Dec 1998) |
| environment and public health | Natural and man-made environments and their impact on public health. (12 Dec 1998) |
| united states public health service | See: USPHS. (12 Dec 1998) |
| ABO antigens | <haematology, immunology> A system of genetically determined antigens (proteins) located on the surface of the erythrocyte. The presence of these specific antigens gives a blood its unique properties. Because of the antigen differences existing between individuals, blood groups are significant in blood transfusions, maternal-foetal incompatibilities (erythroblastosis foetalis), tissue and organ transplantation. (27 Sep 1997) |
| Am antigens | Allotypic determinants (antigens) on human immunoglobulin alpha heavy chains. (05 Mar 2000) |
| antigens | Substances which are capable, under appropriate conditions, of inducing a specific immune response and of reacting with the products of that response, that is, with specific antibodies or specifically sensitised T-lymphocytes, or both. Antigens may be soluble substances, such as toxins and foreign proteins, or particulates, such as bacteria and tissue cells; however, only the portion of the protein or polysaccharide molecule known as the antigenic determinant (epitopes) combines with antibody or a specific receptor on a lymphocyte. (12 Dec 1998) |
| antigens, archaeal | Substances of archaeal origin that have antigenic activity. (12 Dec 1998) |
| antigens, bacterial | Substances elaborated by bacteria that have antigenic activity. (12 Dec 1998) |
| antigens, CD | <immunology> Differentiation antigens residing on human leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similiar reactivity with certain subpopulations of antigens. The subpopulations of antigens are also known by the same CD designation. (12 Dec 1998) |
| antigens, CD1 | <immunology> Glycoproteins expressed on cortical thymocytes and on some dendritic cells and B-cells. Their structure is similar to that of MHC class I and their function has been postulated as similar also. Cd1 antigens are highly specific markers for human langerhans cells. (12 Dec 1998) |
| antigens, CD11 | <immunology> A group of three different alpha chains (CD11a, CD11b, CD11c) that are associated with an invariant CD18 beta chain (antigens, CD18). The three resulting leukocyte-adhesion molecules (receptors, leukocyte adhesion) are lymphocyte function-associated antigen-1, macrophage-1 antigen, and antigen, p150,95. (12 Dec 1998) |